Friedman Lab

Beth Israel Deaconess Medical Center

Boston · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2025

APOL1 Nephropathy: Linking Genetics and Mechanisms

SUMMARY: Two coding variants (G1 and G2, also referred to as "risk variants" or RV) in the APOL1 gene account for much of the high rate of kidney disease in people of recent African ancestry. Evidence supports the idea that APOL1 risk variants (RV) promote kidney disease through toxic, gain-of-function activity despite a largely recessive pattern of risk inheritance. Investigators have speculated that recessive gain-of-function toxicity may be due to a dose threshold requiring two risk alleles or alternatively a “G0 rescue” model where G0 can protect against the toxic effect of the risk variants, potentially via direct interaction. The work proposed here will provide insight into this…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Beth Israel Deaconess Medical Center